Business Context and Reporting Period
This Form 8-K is a current report filed by Reshape Lifesciences Inc. (trading symbol: RSLS) on April 8, 2022. The filing addresses a change in the company's independent registered public accounting firm. Note: The request metadata lists "Vyome Holdings, Inc," but the filing text explicitly identifies the registrant as Reshape Lifesciences Inc.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the resignation of the auditor.
Material Changes
- Auditor Resignation: BDO USA, LLP ("BDO") resigned as the independent registered public accounting firm effective upon the filing of the Company's Form 10-Q for the quarter ended March 31, 2022.
- No Disagreements: The Company reported no disagreements with BDO regarding accounting principles, practices, financial statement disclosures, or auditing scope/procedures during the fiscal years ended December 31, 2021 and 2020, or the interim period through April 8, 2022.
- No Reportable Events: There were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K during the relevant periods.
- Successor Status: As of the date of this report, the Company has not engaged a new independent registered public accounting firm.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or specific risk factors beyond the standard disclosure of the auditor change. The primary contingency noted is the ongoing process to engage a new independent registered public accounting firm, which will be disclosed once completed.
Investor Verification Checklist
- Verify the reason for BDO USA, LLP's resignation by reviewing the attached letter (Exhibit 16.1) for any additional context not included in the main text.
- Monitor subsequent filings for the appointment of a new independent registered public accounting firm.
- Review the upcoming Form 10-Q for the quarter ended March 31, 2022, to assess the financial impact of the auditor change and the company's operational status.
- Confirm the discrepancy between the request metadata ("Vyome Holdings, Inc") and the filing registrant ("Reshape Lifesciences Inc") to ensure the correct entity is being analyzed.